As of Jul 21
| -0.02 / -0.84%|
The 4 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 5.00, with a high estimate of 9.00 and a low estimate of 3.50. The median estimate represents a +111.86% increase from the last price of 2.36.
The current consensus among 6 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.